##plugins.themes.academic_pro.article.sidebar##

Download
pdf
Statistic
Read Counter : 34 Download : 24

##plugins.themes.academic_pro.article.main##

Abstract

Toxic hepatitis, an inflammatory condition of the liver caused by exposure to toxins, presents a significant health challenge. While conventional treatments focus on removing the causative agent and supporting liver function, the potential role of biologically active supplements (BAS) in managing and mitigating the effects of toxic hepatitis is gaining attention. This paper examines the current understanding of toxic hepatitis and the rationale for using BAS. It explores the types of BAS, including antioxidants, hepatoprotective agents, and anti-inflammatory compounds, that may offer therapeutic benefits in the context of toxic liver injury. The study analyzes the existing evidence regarding the efficacy, safety, and appropriate use of these supplements, highlighting the importance of a personalized and evidence-based approach. It also emphasizes the necessity of understanding potential interactions with conventional treatments and the need for further research to clarify the optimal role of BAS in the management of toxic hepatitis

Keywords

Toxic Hepatitis Biologically Active Supplements Liver Injury Hepatoprotective Agents

##plugins.themes.academic_pro.article.details##

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite
Abdullayeva Mavsumakhon Qo’ldashevna. (2024). The Correct Use Of Biologically Active Supplements In Toxic Hepatitis. Texas Journal of Medical Science, 39, 93–95. https://doi.org/10.62480/tjms.2024.vol39.pp93-95
Crossref
Scopus
Google Scholar
Europe PMC

References

  1. Khalimova K. M. et al. Clinical neurological and diagnostic aspects of headaches with congenital
  2. precerebral angiodysplasia //Toshkent tibbiyot akademiyasi axborotnomasi. – 2019. – №. 2. – С. 132-134.
  3. Salokhiddinov M., Rahmatullaeva G. The role of pathological deformations of the main arteries of
  4. the brain In the development< bold> of stroke //CEREBROVASCULAR DISEASES. –
  5. ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND : KARGER, 2018. – Т. 45. – С. 473-
  6. Rahmatullaeva G. Molecular Genetic Features Of Polymorphism Of The Gene Col4a1 Rs605143
  7. G/A In The Development Of Pathological Deformations Of Cerebral Vessels In Patients With Migraine (P2.
  8. //Neurology. – 2018. – Т. 90. – №. 15_supplement. – С. P2. 241.
  9. Khalimova K., Rakhmatullaeva G., Rashidova N. Role of the insolvency connective tissue in the
  10. development of pathological deformation of cerebral vessels in patients with primary headaches //Journal of
  11. the Neurological Sciences. – 2013. – Т. 333. – С. e512-e513.